Mediolanum International Funds Ltd has supercharged its investment in Regeneron Pharmaceuticals, increasing its stake by a ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $270.89, a high estimate of $284.00, and a low estimate of $260.00. This upward ...

The SPDR® S&P Biotech ETF rebounded over 20% since lows in April, despite changes at the FDA that could have signaled a ...

We expect Amgen AMGN to beat expectations when it reports second-quarter 2025 results on Aug. 5 after market close. In the ...

Elevance Health just elected Steven Collis as an independent director. He’s joining the Audit and Finance Committees, which ...